Nick Goeden

Nick Goeden serves as Chief Technology Officer at Capsida Biotherapeutics. Capsida Biotherapeutics operates in the biotechnology sector with approximately 120.0 employees. The company is headquartered in Los Angeles, California. Capsida Biotherapeutics generates annual revenue of 2000000.0. To date, Capsida Biotherapeutics has raised 230000000.0 in total funding, with the most recent round being Private Equity.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 WordPress.org Google Font API Google Tag Manager Mobile Friendly Nginx reCAPTCHA Android

biotechnology aav engineering gene therapy biopharmaceuticals protein engineering analytical development process development aav immunology aav capsids cns targeting disease modification clinical development intravenous administration engineered capsids preclinical studies manufacturing processes neurodegenerative diseases therapeutic index gene delivery capsid engineering patient-centered approach strategic collaborations orphan drug designation disease modifying therapies stxbp1 encephalopathy parkinson's disease friedreich's ataxia preclinical proof of concept cargo optimization high-throughput screening neuron transduction disease-targeted therapies automated screening translational biology genetic medicine clinical trials biotechnology solutions contract manufacturing quality control patient advocacy central nervous system therapeutic expression safety profiles biopharmaceutical innovation unique capsid design elevated neuronal expression diminished liver targeting neurodevelopmental disorders non-invasive gene therapies community engagement regulatory expertise biotech partnerships innovative treatment strategies multidisciplinary approach long-term therapy efficacy targeted therapies cns disorders adeno-associated virus gene replacement gene editing gene silencing disease-modifying treatments rare diseases stxbp1 developmental encephalopathy proprietary platform safety profile manufacturing capabilities biopharmaceutical partnerships patient-centric approach innovative therapies comprehensive development therapeutic potential non-invasive treatments gene therapy pipeline collaboration with abbvie crispr therapeutics biotechnology industry precision medicine health care health wellness & fitness hospital & health care mechanical or industrial engineering

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Nick Goeden, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Nick Goeden's Position in the MessageCEO Database

• •Nick Goeden is 1 of 1 verified executive contact we track at Capsida Biotherapeutics.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •12,901 verified executive contacts in California are in the database.
• •5 verified contacts work at biotechnology companies in the 120.0 employee range (same size as Capsida Biotherapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Nick Goeden directly?

Nick Goeden's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Capsida Biotherapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Nick Goeden work for?

Nick Goeden is Chief Technology Officer at Capsida Biotherapeutics, a company in the biotechnology sector with 120.0 employees. The company is based in Los Angeles, California.

Can I pitch or sell to Nick Goeden?

As Chief Technology Officer at Capsida Biotherapeutics, Nick Goeden is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Nick Goeden directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Nick Goeden in?

Nick Goeden works in the biotechnology industry as Chief Technology Officer at Capsida Biotherapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Nick Goeden's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Nick Goeden's profile is kept up-to-date with the latest available information.

Last updated: June 30, 2026